Among Sino Biological’s 1,100+ recombinant cytokines, their GMP-grade stem cell research cytokines ... importance of sex-specific in vitro models for neurological research and drug discovery. Zymo ...

Scientists have progressed from merely provoking an anti-cancer immune response to designing it ...

Boster Biological Technology advances biotechnology research with its cutting-edge multiplex ELISA service, delivering ...

IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Gearing Up to Initiate Phase 3 Ovarian Cancer Trial Imunon, Inc. (NASDAQ:IMNN) is continuing preparations to conduct a Phase 3 clinical trial of ...

Jazz and Werewolf say that WTX-613 is designed to deliver the cytokine ... The drug adds to a growing oncology pipeline at Jazz, currently headed by recently-approved Rylaze (recombinant ...

SON-1010, after receipt of data suggesting clinical benefit when administered as a monotherapy in patients with advanced solid tumors, enters ...

AB2 Bio Ltd., a biotechnology company developing innovative therapies for the treatment of severe systemic hyperinflammatory diseases and conditions driven by IL-18, announced today it has entered ...

Blood DC antigen 2 (BDCA2) is exclusively expressed on pDCs and its antibody BIIB059 has demonstrated preliminary efficacy and excellent safety in patients with SLE or cutaneous lupus erythematosus ...

Roche has given two early-phase bispecifics the heave-ho, ending work on a HER2xCD3 prospect and an IL-15 candidate it picked ...

Stifel analyst James Condulis writes Cytokinetics’ aficamten is an exceptional drug as it sets a strong competitive standard for a multi-billion-dollar obstructive hypertrophic cardiomyopathy ...